10 Best Wireless Telecom Stocks To Own For 2014

Last week�� announcement of Russia�� USD400 billion deal to export its natural gas to China has global liquefied natural gas (LNG) players scrambling.

The good news, as we noted last week, is that as staggering as the numbers are, the 30-year contract between Russia�� state-controlled OAO Gazprom and the state-owned China National Petroleum Corp (CNPC) will fulfill just 9 percent of projected Chinese gas demand by the time natural gas starts flowing through East Siberian pipelines toward the end of this decade.

And the Chinese are shrewd enough to know that the Russians are only as dependable as current exigencies allow. In other words, they understand the importance of diversification when it comes to meeting the country�� critical energy demands. So while Canada�� political and regulatory process is proceeding at a glacial pace, the country�� relative stability is a welcome complement to its resource riches.

Top 10 Bank Companies For 2015: T-Mobile US Inc (TMUS)

T-Mobile US, Inc., formerly MetroPCS Communications, Inc., incorporated on March 10, 2004, is a wireless telecommunications carrier, which offers wireless broadband mobile services primarily in metropolitan areas in the United States, including the Atlanta, Boston, Dallas/Fort Worth, Detroit, Las Vegas, Los Angeles, Miami, New York, Orlando/Jacksonville, Philadelphia, Sacramento, San Francisco and Tampa/Sarasota metropolitan areas. Its flagship brands include T-Mobile and MetroPCS. As of December 31, 2012, it held licenses for wireless spectrum suitable for wireless broadband mobile services covering a total population of 144 million people in and around many of the metropolitan areas in the United States. It provides its services using code division multiple accesses (CDMA) networks using 1xRTT technology and evolution data optimized (EVDO) and fourth generation long term evolution (4G LTE).

The Company has roaming agreements with other wireless broadband mobile carriers that allow them to offer its customers service in many areas when they are outside its service area. These roaming agreements, together with the area it serve with its own networks, allows its customers to receive service in an area covering over 280 million in total population under the Metro USA brand. The Company sells products and services to customers through its Company-owned retail stores, as well as indirectly through relationships with independent retailers and third party dealers. Its service allows its customers to place unlimited local calls from within its local service area and to receive unlimited calls from any area while in its service area, for a flat-rate monthly service fee. For additional usage fees, it also provide certain other value-added services. All of these plans require payment in advance for one month of service. If no payment is made in advance for month of service, service is suspended at the end of the month that was paid for by the customer and, if the customer does not pay within 30 day! s, the customer is terminated. It believes its service plans differentiate them from the more complex plans and long-term contract requirements of traditional wireless carriers.

The Company voice services allow customers to place voice calls to, and receive calls from, any telephone in the world, including local, domestic long distance, and international calls. Its voice services also allow customers to receive and make calls while they are located in areas served by its networks and in those geographic areas served by the networks of certain other wireless broadband mobile carriers with whom it has roaming arrangements. The Company�� data services include text messaging services (domestic and international); multimedia messaging services; mobile Internet access; mobile instant messaging; location-based services; social networking services; push e-mail; multimedia streaming and downloads; and services provided, depending on the network and locale, through the Binary Runtime Environment for Wireless, or BREW, Blackberry, Windows, and the Android platforms, such as ringtones, ring back tones, games, content, and applications.

The Company�� Custom calling features offers custom calling features, including caller ID, call waiting, three-way calling and voicemail. Its Advanced handsets sells a variety of feature phones, and increasingly, smartphones, predominately manufactured by nationally recognized manufacturers for use on its network, including models that have cameras, include HTML browsers, play music, play streaming audio, display streaming video and downloaded video, and have other features facilitating digital data. It sells a variety of handsets using vendor or handset specific operating systems, such as BREW, Blackberry, Windows, and the Android operating system.

The Company provides its wireless broadband mobile services using paired personal communications services (PCS), spectrum and advanced wireless services, or AWS, spectrum. In addition, it holds a! license ! for 12 MHz of paired 700 MHz Lower Band A spectrum in the Boston-Worcester, MA/NH/RI/VT basic economic area (BEA), which, unless it receives a waiver from the Federal Communications Commission (FCC), of the four year construction requirements, it plans to construct in the first half of 2013. In each of its metropolitan areas where irt provides service. As of December 31, 2012, it holds between 10 mega hertz (MHz) and 60 MHz of paired spectrum and on average it has approximately 22 MHz of paired spectrum in the metropolitan areas it serves. In the aggregate, as of December 31, 2012, it offers wireless broadband mobile services using its own network.

The Company operates 1xRTT CDMA networks in all of the metropolitan areas it serves and it has upgraded its networks to 4G LTE in all of metropolitan areas. It also has deployed EVDO at selected high use sites in its CDMA network to increase network data capacity to meet the growing data needs of iy customers. Its network includes a mobile switching center (for CDMA), enhanced packet core (for 4G LTE), and IP core. These serve several purposes, including routing traffic, managing call handoffs, and managing access to the public switched telephone network (for CDMA) or the Internet (CDMA and 4G LTE). These network elements also provide access to voicemail and other value-added services, base stations (for CDMA) or eNodeBs (for 4G LTE), cell sites or distributed antenna system (DAS), nodes, and backhaul facilities, which carry traffic to and from its cell sites and its switching or enhanced packet core facilities, consisting of a combination of dedicated circuits, cable, fiber, and microwave facilities.

Its cell sites in the network are co-located, meaning its equipment is located on leased facilities that are owned by third parties who retain the right to lease the locations to additional carriers and in many cases other wireless broadband mobile service providers already have facilities at such locations. The switching centers and na! tional op! erations center provide around-the-clock monitoring of its network. Its switches connect to the public switched telephone network through fiber rings leased from third-parties, which transmit originating and terminating traffic between its equipment and local exchange and long distance carriers. It also has negotiated interconnection agreements with relevant local exchange carriers, or LECs, in its service areas. It uses third-party providers for domestic and international long distance services, international SMS interconnection with the public switched network and other carriers, roaming services, and the majority of its backhaul services.

The Company competes with AT&T, Verizon Wireless, Sprint Nextel, T-Mobile USA , Deutsche Telekom, Clearwire, Dish Network , Time Warner Cable, Comcast, Cox Communications, Cricket Communications, Leap Wireless International and Google.

Advisors' Opinion:

• [By Jon C. Ogg]

  We still have many key oil and energy companies reporting in the week ahead but we have now seen the sector leaders report earnings. Earnings previews have been prepared for the following stocks:

  CME Group Inc. (NASDAQ: CME) Hertz Global Holdings Inc. (NYSE: HTZ) Kellogg Company (NYSE: K) DirecTV (NASDAQ: DTV) Office Depot Inc. (NYSE: ODP) and OfficeMax Incorporated (NYSE: OMX) Tesla Motors Inc. (NASDAQ: TSLA) T-Mobile US, Inc. (NYSE: TMUS) American Water Works Company Inc. (NYSE: AWK) Duke Energy Corp. (NYSE: DUK) QUALCOMM Inc. (NASDAQ: QCOM) Time Warner Inc. (NYSE: TWX) Whole Foods Market Inc. (NASDAQ: WFM) Groupon Inc. (NASDAQ: GRPN) Molycorp Inc. (NYSE: MCP) The Walt Disney Company (NYSE: DIS) Priceline.com Inc. (NASDAQ: PCLN) The Wendy’s Company (NYSE: WEN)

  CME Group Inc. (NASDAQ: CME) reports earnings on Monday morning. With all of the exchange mergers of the last decade this remains one of the dominant exchanges. Estimates are $0.73 EPS and $713.3 million in revenue. Keep in mind that this exchange is now worth $25 billion. At $74.70, the consensus analyst price target is only just barely higher at almost $75.50.

• [By Adam Levy]

  AT&T (NYSE: T  ) added 566,000 postpaid customers in the fourth quarter. That was good enough to best Sprint (NYSE: S  ) , but trailed Verizon (NYSE: VZ  ) and T-Mobile (NYSE: TMUS  ) . A huge number of those net new customers were tablet owners -- 440,000.

• [By Tom Rojas var popups = dojo.query(".socialByline .popC"); popups.forEach(func]

  Sprint Corp. on Tuesday decided to end its pursuit of T-Mobile US Inc.(TMUS) in the face of stiff opposition from regulators and replace Chief Executive Dan Hesse with Marcelo Claure. Meanwhile, Iliad S.A.(ILD.FR) said it plans to push ahead with its offer for T-Mobile. Sprint shares dropped 17% to $6.04 premarket. T-Mobile shares fell 8.6% to $31.

• [By Ben Rooney]

  Sprint (S) and T-Mobile (TMUS) have also been offering customers the chance to get more data without paying more.

  As smartphones become more sophisticated, consumers have been demanding more data to increase their ability to send photos, download music and watch videos.

10 Best Wireless Telecom Stocks To Own For 2014: KDDI Corp (KDDIF)

KDDI CORPORATION is a telecommunications company. The Mobile Telecommunication segment is engaged in the provision of mobile communications services, including voice and data services, and mobile WIMAX services, as well as the sale of mobile communication terminals and the provision of contents. The Fixed-line Telecommunication segment provides broadband services, including fiber to the home (FTTH) and cable television (TV) services, as well as domestic and overseas communication services, data center services and information and communication technology (ICT) solution services. The Others segment is involved in the operation of call centers and the development of research and advanced technology. On December 2, 2013, it transferred all shares of a wholly owned subsidiary, JAPAN CABLE NET LIMITED to another subsidiary. In December 2013, the Company acquired the entire share capital in Yugen Kaisha Cosmos. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- With the yen holding on to its gains and investors cautious as earnings season kicks off, Japanese stocks slid lower Friday after closing the previous day with some late-session gains. The Nikkei Stock Average (JP:NIK) fell 0.9% to 14,358.28, with the Topix down 0.8%, as the dollar bought 97.36 yen, little changed from 24 hours earlier. The relatively strong yen weighed on some names with high global exposure, as Sharp Corp. (JP:6753) (SHCAF) lost 1%, Pioneer Corp. (JP:6773) (PNCOF) dropped 1.6%, and Bridgestone Corp. (JP:5108) (BRDCF) fell 1.2%. An outlook cut from Canon Inc. (JP:7751) (CAJ) helped send its shares down 1%, while rival Nikon Corp. (JP:7731) (NINOF) lost 1.8%, though Olympus Corp. (JP:7733) (OCPNF) gained 1%. Telecoms were weak, with Softbank Corp. (JP:9984) (SFTBF) falling 2.5%, KDDI Corp. (JP:9433) (KDDIF) down 1.7%, and NTT DoCoMo Inc. (JP:9437) (NTDMF)

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Japanese stocks opened sharply higher Monday, with the Nikkei Stock Average (JP:NIK) advancing 1.1% to 14,242.86 after falling 2.8% Friday, as end-of-the-week gains for U.S. shares and some earnings news helped lift the market. The Topix also saw solid gains, up 0.8% in early moves. Major advances included a 2.5% rise for Hitachi Ltd. (JP:6501) (HTHIF) , a 4.1% surge for Mitsubishi Motors Corp. (JP:7211) (MMTOF) , and a 2.6% improvement for KDDI Corp. (JP:9433) (KDDIF) after the Nikkei business daily said the telecom will report a 50% increase for operating profit in the fiscal first half compared to a year earlier. Sony Corp. (JP:6758) (SNE) added 2% after scoring a Credit Suisse upgrade to outperform. Shares of NTT DoCoMo Inc. (JP:9437) (NTDMF) traded 1.1% higher after posting above-forecast quarterly results Friday, while JFE Holdings Inc. (JP:5411) (JFEEF) fell 3.2% after the steel producer also reported earnings.

10 Best Wireless Telecom Stocks To Own For 2014: Sprint Corp (S&LS)

Sprint Corporation, incorporated on May 10, 2012, offers a range of wireless and wireline communications services to consumers, businesses and government users. On July 10, 2013, the Company, SoftBank Corp. and Sprint Nextel Corporation (Sprint Nextel) completed the merger. In the Merger, Sprint Corporation was merged into Sprint Nextel, New Sprint became the parent company of Sprint Nextel, with Sprint Nextel becoming its direct wholly owned subsidiary, and Sprint Nextel changed its name to Sprint Communications, Inc.

The Company develops, engineers and deploys technologies, including the first wireless fourth generation (4G) service from a national carrier in the United States; offering mobile data services, prepaid brands, including Virgin Mobile USA, Boost Mobile, and Assurance Wireless; instant national and international push-to-talk capabilities, and a global Tier 1 Internet Service. The Company also offers unlimited data services.

Advisors' Opinion:

• [By Holly LaFon]

  Since Wilmers & Co. took over M&T Bank in 1983 the bank has acquired 23 banks and Savings and Loans (S&Ls) ��expanding from a single state to seven ��and assets have grown from $2 billion to $110 billion. M&T's branch count has grown from 60 to over 870. The bank currently boasts a customer base of over 2 million retail household customers and nearly 220,000 commercial customers.

10 Best Wireless Telecom Stocks To Own For 2014: China Teletech Holding Inc (CNCT)

China Teletech Holding, Inc., formerly Guangzhou Global Telecom, Inc., incorporated on March 29, 1999, is a distributor of pre-paid calling card and integrated mobile phone handsets and a provider of mobile handset value-added services. The Company serves as one of principal distributors of China Telecom, China Unicom, and China Mobile products in Guangzhou City. The Company is also developing an on-line refill platform with China Mobile to develop its on-line business in the Guangdong Province. On March 30, 2012, the Company acquired China Teletech Limited.

The Company operates its business through its subsidiaries in China: Guangzhou Renwoxing Telecom Co., Ltd., Guangzhou Global Telecommunication Co., Ltd., Guangzhou Rongxin Technology Co., Ltd., and Shenzhen Rongxin Investment Co., Ltd. The Company also engages in the business of wholesale and distribution of mineral water, as well as trading of wine in China. The Company has cooperative distribution relationships with Panasonic, Motorola, LG, GE, Bird, Samsung corporations for their mobile handsets.

Advisors' Opinion:

• [By MARKETWATCH]

  HONG KONG (MarketWatch)-- Hong Kong stocks rose early Thursday, as China Mobile Ltd. shined on news of iPhone pre-orders hitting 1 million units. The Hang Seng Index (HK:HSI) added 0.6% to 23,032.09. Market heavyweight China Mobile (HK:941) (CHL) rallied 0.9%, as the world's largest mobile carrier said it has received more than 1 million pre-orders for the iPhone before it goes on sale in the carrier's stores on Friday, at a time when Apple Inc. (AAPL) Chief Executive Tim Cook visited Beijing for future cooperation between the two giants. Telecom equipment shares also advanced, with ZTE Corp. (HK:763) (ZTCOF) rising 1.2%. Meanwhile, China Mobile's smaller rivals slipped, as China Unicom (HK:762) (CHU) dropped 0.7%, and China Telecom (HK:738) (CNCT) fell 0.5%. China South City Holdings (HK:1668) , a developer of logistics and trade centers, surged 56%, after the company announced that Internet giant Tencent Holdings (HK:700) (TCTZF) would invest about 1.5 billion Hong Kong dollars ($195 million) for an almost 10% stake in the developer in order to expand their business online, including e-commerce and online payment services. Tencent Holdings (HK:700)

10 Best Wireless Telecom Stocks To Own For 2014: Eutelsat Communications SA (ETL)

Eutelsat Communications SA is a France-based holding company that provides fixed satellite services. It provides four types of services, including broadcast services, such as direct-to-home and professional broadcasting; broadband services, comprising broadband Internet access; telecoms and data services to ensure permanent communications links from all points of the globe, establish or restore communications in an emergency and multicast content; as well as mobile and maritime communications, such as fleet management and on- and off-shore broadband maritime communications. It operates a fleet of satellites covering Europe, the Middle East, North and sub-Saharan Africa, as well as parts of Asia and the Americas. In January 2014, it acquired Satelites Mexicanos, S.A. de C.V. and together with SES SA have completed the sale to EchoStar Corp. of Solaris Mobile Ltd. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Eutelsat Communications SA (ETL) declined 6.2 percent to 21.02 euros after predicting sales will grow by more than 2.5 percent for the year 2013 to 2014. The company, which operates 31 satellites, forecast growth of more than 5 percent for the following two years through June 2016. JPMorgan Chase & Co. cut its price target for the stock to 24 euros from 33 euros, saying analysts��will probably reduce their estimates following the company�� revised guidance.

10 Best Wireless Telecom Stocks To Own For 2014: TechnoConcepts Inc (TCPS)

TechnoConcepts, Inc. (TCI), incorporated in May 2003, is in the business of designing, developing, manufacturing and marketing wireless communications semiconductors. The Company has begun manufacturing wireless transmitter and receiver microchips, based on its technology, and produced its engineering run in August 2006. The technology, which TCI calls True Software Radio, is designed to improve the way that wireless signals are received and transmitted, by making possible device-to-device communication across otherwise incompatible networks and wireless standards. On October 17, 2005, the Company, through its wholly owned subsidiary, Asante Acquisition Corp. completed reorganization with RegalTech Inc. RegalTech's name was changed to Asante Networks Inc. (Asante).

In December 2005, the Company formed Jinshilin Techno Ltd. (Jinshilin Techno) as its wholly owned subsidiary based in Shanghai, China. The Company organized Jinshilin Techno to provide marketing, sales and technical support for True Software Radio technology in China. On April 21, 2006, Jinshilin Techno acquired Internet television (IPTV) set-top box (STB) technology through license agreements with Jinshilin Technologies Development Company Ltd. (Jinshilin). Jinshilin Techno offers an IPTV set-top box that features voice over Internet protocol (VOIP), capability and can receive Internet protocol (IP) data transmissions through the household electrical power grid.

Asante Networks Inc. provides Ethernet networking solutions for Apple Computer and the small-to-medium business retail markets, offering the IntraCore and FriendlyNET product families, integrating voice, data, and video over wireless and wired networks with unified management and authentication. In April 2006, Asante announced the release of 2-chip switch solution, the IntraCore 38480. The IntraCore 38480 provides no frame loss and full-wire speed with minimized latency. With 96-gigabit switching fabric, the IntraCore 38480 supports full-wire speed on all ! ports. It has advanced traffic control based on L2-L7 data of incoming frames.

The Company's True Software Radio technology makes possible for wireless transmitters and receivers, as well as the radio signal processing, to be fully controlled and reconfigured by software commands across a range of frequencies and frequency bands. Its True Software Radio technology is a delta-sigma microchip architecture that converts radio frequency signals directly into digital data for the wireless receiver and directly from digital data into radio signals for the wireless transmitter. True Software Radio microchips replace the analog front end, intermediate frequency (I/F) processing, analog-to-digital conversion (ADC), and digital filtering sections of conventional wireless transmitters and receivers.

Advisors' Opinion:

• [By Peter Graham]

  Small cap tech stocks TechnoConcepts, Inc (OTCMKTS: TCPS), Unisource Corporation (OTCMKTS: USRC) and Strategic Global Investments, Inc (OTCMKTS: STBV) have been getting some attention lately in various investment newsletters thanks to promotions. Of course, there is nothing wrong with properly disclosed promotions, but they can backfire on the unwary as its really up to investors or traders alike to do their own due diligence before investing or trading. With that in mind, here is a quick reality check about three small cap tech stocks getting a bit of attention lately:

  TechnoConcepts, Inc (OTCMKTS: TCPS) Has the Yield Sign Replaced on Its OTC Page

  Small cap TechnoConcepts is a wireless technology company currently holding patents and other intellectual property. On Friday, TechnoConcepts fell 0.45% to $15.58 for a market cap of $415.28 million plus TCPC is up 1.1% over the past year and up 6% since April 2012 according to Google Finance.

10 Best Wireless Telecom Stocks To Own For 2014: Intelsat SA (I)

Intelsat S.A., incorporated on July 18, 2011, is a satellite services business, providing a layer in the global communications infrastructure. The Company operates satellite capacity, holds orbital location rights, contract backlog, serve commercial customers and deliver services. It provides diversified communications services to the world�� media companies, fixed and wireless telecommunications operators, data networking service providers for enterprise and mobile applications, multinational corporations and Internet service providers (ISPs). It is also the provider of commercial satellite capacity to the United States government and other select military organizations and their contractors.

The Company has a satellite fleet comprised of more than 50 satellites, covering 99% of the Earth�� populated regions. Its fleet, combined with the IntelsatOne terrestrial fiber network and a collection of teleports, form a singular unmatched global infrastructure to meet any communications requirement. As the provider of satellite services, the Company provides mission critical communication services.

Advisors' Opinion:

• [By Rich Duprey]

  Satellite services provider Intelsat (NYSE: I  ) announced yesterday its third-quarter dividend of $0.71875 per share on its 5.75% Series A mandatory convertible junior non-voting preferred stock, which trades on the NYSE under the symbol I.PRA.

• [By The Specialist]

  Subject to ongoing evaluation and analysis, the Reporting Person may consider certain plans or proposals to increase shareholders' value that may relate to or may result in (I) a change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; and/or (ii) a material change in the present dividend policy of the Issuer

• [By Todd Sullivan]

  HHC has increased all our ownership percentage through the repurchasing of outstanding warrants.

  From the 13D/A
  On December 31, 2013, certain of the Reporting Persons entered into swaps for the benefit of certain Pershing Square Funds. Under the terms of the swaps, (i) the relevant Pershing Square Funds will be obligated to pay to the bank counterparty any negative price performance of the 5,399,839 notional number of Common Shares subject to the swaps as of the expiration date of such swaps, plus interest rates set forth in the applicable contracts, and (ii) the bank counterparty will be obligated to pay the relevant Pershing Square Funds any positive price performance of the 5,399,839 notional number Common Shares subject to the swaps as of the expiration date of the swaps. During the term of the swaps, cash will be paid by the bank counterparty to the relevant Pershing Square Fund in an amount equal to the amount of notional distributions or dividends paid by the Issuer in respect of such notional number of Common Shares. All balances will be settled in cash. The Pershing Square Funds��counterparties for the swaps include entities related to Citibank, Nomura, Soci茅t茅 G茅n茅rale and UBS. The swaps do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparty thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership of any Common Shares that may be referenced in the swap contracts or Common Shares or other securities or financial instruments that may be held from time to time by any counterparty to the contracts.

Tackling Hot-Button Topics

Top 5 Information Technology Companies For 2015

For those who may not know, each month we host a joint web chat for subscribers of The Energy Strategist (TES) and MLP Profits. The chat is conducted by Igor Greenwald, managing editor for TES and chief investment strategist for MLP Profits, and myself.

We place a priority on answering questions about portfolio holdings and recommendations during the chat, but often we get questions about companies we don’t currently recommend. Sometimes we may get questions that require an extended answer, or there may just be so many questions we can’t get to them all. For the most recent chat there were three MLP questions that warrant some elaboration.

Q: Do you anticipate any impact on MLP share prices in a rising interest rate environment?

We got a couple of questions about the effect of interest rates on expected MLP unit performance. Igor’s view is that the spring/summer MLP correction sort of inoculated against a repeat, and further that the economy isn’t strong enough to support significantly higher rates for a good long while. And as the economy strengthens, it should generate plenty of demand for new energy infrastructure, helping the MLP sector grow, he argues.

I would add that those MLPs that are highly leveraged will be most at risk as rates rise. I would further avoid those that have had a significant run-up that has depressed the yields to low levels. A low-yielding MLP like Phillips 66 Partners (NYSE: PSXP), which had a very big rally from its initial IPO price, could be particularly vulnerable to higher interest rates.

Q: What are the pros and cons of holding an MLP in a retirement account? And which would you recommend?

Opinions on this are split. A big advantage of MLP investing is the potential for def! erring taxes on earnings. However, the income in retirement accounts is already tax deferred. Further, it is possible that the retirement account could end up owing additional taxes on MLP distributions, reducing the potential return to investors. Retirement accounts are taxed on “unrelated business taxable income” (such as partnership income) in excess of $1,000 in the aggregate. As a result, many financial planners  recommend that you not complicate your retirement account with MLPs.

Others argue that the steady cash distributions are a safe, conservative way to build up the value of the retirement account over time, even if the account ends up having to pay some taxes. The fact that the MLP isn’t paying corporate income taxes is a significant advantage over time with respect to its ability to generate higher income over time than would be possible for a corporation.

My view is that you first want to make sure that any of your fully taxable investments are protected in retirement accounts to the greatest possible extent before you start to consider putting MLPs in your retirement account. For example, investors with both taxable and tax-deferred investment accounts would generally be better off holding MLPs in the taxable accounts, where their tax deferral benefit would be more valuable, and where they would not generate a liability for unrelated business taxable income.

Of course, some MLP affiliates and/or sponsors are tax-paying corporations, and their shares can be held in a retirement account. MLP Profits portfolio picks suitable for IRA accounts include Kinder Morgan (NYSE: KMI), Williams (NYSE: WMB), Targa Resources (NYSE: TRGP) and Navios Maritime Partners (NYSE: NMM), all of which pay dividends and issue the 1099 miscellaneous income forms, rather than the more complicated K-1’s from partnerships.

Q: Linn Energy (NYSE: LINE) seems to have gotten thru the SEC looking them over. The merger with Berry seems to be on track, although at a hi! gher purc! hase price. Do you think Linn is a good investment going forward?

This particular question was answered in the chat, but it warrants some additional commentary. We got half a dozen queries on Linn Energy during the chat, so there is obviously still a lot of interest there. Igor’s answer to this question was “All of that is true, and I expect the merger to close by year’s end, but I think Linn has some structural issues that go beyond Berry with its debt load and past acquisition quality, so I’m steering clear. There are better upstream MLPs in our portfolios.”

I would add that we have been pretty steadfast in believing that the SEC inquiry wouldn’t turn up anything substantive. However, we couldn’t recommend Linn with that inquiry hanging over the partnership. MLP investors in general are not looking to take on that kind of risk, and I suspect most didn’t think it was possible to see Linn drop like it did (down ~40 percent over the summer). This kind of volatility might be acceptable for aggressive speculators, but that doesn’t fit the profile of most MLP investors.

Now that the SEC cloud appears to be lifting and the merger with Berry looks to be imminent, we have taken another look at Linn. But after comparing to peer upstream MLPs, we feel that there are safer options, especially given the higher purchase price Linn had to pay for Berry, and Linn’s relatively high debt level. The present dividend yield of nearly 10 percent is certainly attractive, but our view is that the downside risk will continue to be unacceptably high for conservative investors.

(Follow Robert Rapier on Twitter, LinkedIn, or Facebook.)

Boom Year for Dubai Gold and Commodities Exchange

Top 5 Beverage Stocks To Watch Right Now

Over the past year, there has been a boom in gold futures in Dubai, writes John Everington, of The National, who also explains how this boom has become an essential component of the expansion plan in Dubai.

Volumes on the Dubai Gold and Commodities Exchange (DGCX) have surged 56% year over year on the back of strong growth in precious metal contract trades.

On Sunday, November 10, the exchange reported traded volumes, for the ten months to the end of last month, reached 12.17 million contracts, up from 7.78 million in the same period last year.

Gold futures trading surged 60% during October, with 45,928 contracts being traded. Silver futures rose 88% to hit a new monthly high of 2,882 contracts traded.

Precious metals, and gold in particular, are central to the exchange's expansion plans, with a spot gold contract to be launched imminently, according to Gary Anderson, DGCX's chief executive.

"With almost a quarter of all physical gold traded globally passing through Dubai, we believe there is a very strong market for a spot gold contract," he said.

"Such a contract will not only help merchants enhance price risk management and profitability, it will also enhance liquidity in the gold market by removing the need for offshore credit and collateral for gold trading."

The exchange also reported a 63% growth in currency trading in the year to the end of October, with Indian rupee futures increasing in popularity—up 50% in year-to-date trading. They recorded 10.44 million contracts for the year to the end of October.

DGCX Indian rupee futures accounted for 33.69% of the total rupees future market in October, making it the largest exchange offering offshore trading in the contract.

Read more from The National here…

10 Best Building Product Stocks To Own Right Now

10 Best Building Product Stocks To Own Right Now: Analogic Corp (ALOG)

Analogic Corporation (Analogic), incorporated in November 27, 1967, is a technology company that designs and manufactures advanced medical imaging and security systems and subsystems sold to Original Equipment Manufacturers (OEMs) and end users primarily in the healthcare and airport security markets. Analogic operate primarily three segments: Medical Imaging, Ultrasound, and Security Technology. Medical Imaging, which primarily includes systems and subsystems for computed tomography (CT) and magnetic resonance imaging (MRI) medical imaging equipment, Selenium-based detectors for screening and diagnostic applications in mammography. Ultrasound, which designs, manufactures, and distributes ultrasound systems and transducers primarily in the urology, surgery, robotic assisted surgery, anesthesia, and general imaging markets. Security Technology, which includes advanced threat detecting CT systems. In March 2013, it completed the acquisition of Ultrasonix Medical Corporation. In September 2013, the Company announced that it has acquired the remaining ownership stake in PocketSonics, Inc.

Medical Imaging

During the fiscal year ended July 31, 2012 (fiscal 2012), the Company's medical imaging segment, which accounted for approximately 59% of its net revenue, which consists primarily of electronic systems and subsystems for medical imaging, sold globally to OEM producers of CT, MRI, and digital mammography systems. Products under this consist of: X-Ray Detectors, which converts the x-ray energy in a CT machine to useful analog signals for processing in the DAS.

DAS, which are used to process the signals created by the detectors and feed them as a digital stream to a reconstruction computer to create high resolution images. The DAS is designed with many multi-channel circuit boards that pro! cess the analog signals from the detectors and convert them into digital signals through an array of analog to digital.< /p>

converters. DMS, which the brains of the CT sys! tem and consists of both the detector array and the DAS in one package. This system provides its OEM customers a level of integration that allows for lower cost and faster time to market. Integrated Gantries, which is a component of the CT system (detectors, DAS, x-ray tube and power supplies), are mounted on a rotating ring assembly called a gantry. It provides integrated gantries to its OEM customers as another level of integration.

For OEM producers of MRI equipment, it also supplies two key components: gradient amplifiers and radio frequency, or RF, amplifiers. It has developed a range of amplifier solutions for its customers ranging from low-magnetic-field systems (< 0.3 Tesla) to ultra high-field systems (> 7.0 Tesla) used in academic research hospitals.

Gradient Amplifier, which is a power systems used to drive a set of coils located inside the MRI system and around the patient. The coils energize the atomic structure of patients' anatomy in order to develop tissue and structure images. Gradient amplifiers must be specifically designed for different MRI field strengths ranging from 0.3 Tesla to >7.0 Tesla. RF Amplifiers, which is a power systems used to control another set of the coils within the MRI system that are used to read-back the signals from the anatomy generated by the gradient coils. These signals are then processed in a reconstruction computer to create images. The RF amplifiers must have a high signal-to-noise ratio to produce the cleanest images.

The Company's digital mammography products consist primarily of digital mammography selenium-based x-ray detector plates, sold directly to OEM customers for screening and diagnostic applications in mammography. These x-ray detector plates are used by OEMs in mammography systems to convert x-ray signals into high ! resolutio! n two-dimensional (2-D) and three-dimensional (3-D) images of breast tissue to aid in the detection of breast cancer. Its detector plates for mammography applications are sold to! medical ! OEMs for use in products worldwide. Its mammography product portfolio consists of: LMAM, which is its large area detector plate, based on selenium technology, is used primarily for European markets and was recently introduced in the United States market. This detector plate is also compatible with systems that can perform tomosynthesis, which creates 3-D images through a series of exposures to more accurately detect lesions in the breast. SMAM, which is its small area detector plate uses the same selenium-based technology as the LMAM detector and is manufactured primarily for the Asian markets. Within its medical imaging segment, it also designs and manufactures precision motion control systems, which it supplies to OEM customers for use in computer-controlled automation systems primarily in the semiconductor and medical markets.

Ultrasound

The Company's ultrasound segment designs and manufactures procedure-driven ultrasound systems and transduc ers, principally under the B-K Medical brand. These products are primarily for end-user markets in urology and surgery and accounted for approximately 29% of its net revenue in fiscal year 2012. Its ultrasound systems use acoustic waves to generate real-time images of the body's internal anatomy that are used for interventional and medical diagnostic procedures. These ultrasound systems are also used for guiding robotic assisted surgical procedures and for guiding prostate cancer treatment employing a procedure called brachytherapy. It also manufactures and sells advanced ultrasound probes and transducers to medical OEMs.

Security Technology

Utilizing the Company's CT technology, its Security Technology segment designs and manufactures airport security systems and subsystems primarily for checked bag applicat! ions and ! accounted for approximately 12% of its net revenue in fiscal year 2012. These systems generate 3-D images of objects contained w ithin baggage and provide threat analysis of materials conta! ined with! in the bags. The Company sells the checked baggage systems through L-3 Communications Corporation (L-3): eXaminer XLB (High Speed), eXaminer 3DX (Medium Speed) and eXaminer SX (Reduced Size).

The Company competes with General Electric Corporation (GE) and Koninklijke Philips Electronics N.V. (Philips), Hitachi Medical Corporation, Fujifilm, Morpho Detection and Science Applications International Corp. (SAIC).

Advisors' Opinion:

• [By Laura Brodbeck]

  Monday

  Earnings Releases Expected: Analogic Corporation (NASDAQ: ALOG) Economic Releases Expected: U.S. industrial production, U.S. manufacturing production

  Tuesday

• [By Steven Russolillo]

  WATCH FOR: May ADP Jobs Survey (8:15 a.m. Eastern Time): seen +210K; previously +220K. April US Trade Deficit (8:30): seen $40.9B; previously $40.4B. First Quarter Productivity (8:30, second read): seen -3.1%; previously -1.7%. First Quarter Unit Labor Costs (8:30, second read): seen +5.5%: previously +4.2%. May ISM Non-Manufacturing PMI (10:00): seen 55.2; previously 55.2. Analogic(ALOG), Ciena(CIEN), Cooper, Diamond Foods(DMND), J.M. Smucker(SJM), Joy Global(JOY), Piedmont Natural Gas(PNY), UTi Worldwide, Vail Resorts, Vera Bradley(VRA) and VeriFone(PAY) are among companies scheduled to report quarterly results.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Analogic (NASDAQ: ALOG) were down 16.00 percent to $80.11 after the company reported downbeat Q2 earnings. CJS Securities downgraded the stock from Market Outperform to Market Perform and cut the price target from $97.00 to $90.00.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Analogic (NASDAQ: ALOG) were down 16.66 percent to $80.47 after the company reported! downbeat! Q2 earnings. CJS Securities downgraded the stock from Market Outperform to Market Perform and cut the price target from $97.00 to $90.00.

source from Top Stocks For 2015:http://www.topstocksblog.com/10-best-building-product-stocks-to-own-right-now.html

Top Up And Coming Stocks To Invest In 2015

Top Up And Coming Stocks To Invest In 2015: Lear Corp (LEA)

Lear Corporation, incorporated in 1987, is a tier 1 supplier to the global automotive industry. The Company supplies its products to automotive manufacturers with automotive seat systems and related components, as well as electrical distribution systems and related components. The Company has two segments: seating and electrical power management systems (EPMS). The seating segment includes seat systems and related components, such as seat frames, recliner mechanisms, seat tracks, seat trim covers, headrests and seat foam. The EPMS segment includes electrical distribution systems for traditional powertrain vehicles, as well as for hybrid and electric vehicles. As of December 31, 2011, it had 20 joint ventures located throughout Asia, as well as five in North America, two in Europe and Africa and one with operations in all three regions.

Seating Segment

The Seating Segment consists of the design, manufacture, assembly and supply of vehicle seating r equirements. It produces seat systems for automobiles and light trucks that are assembled and ready for installation. In all cases, seat systems are designed and engineered for specific vehicle models or platforms. It has developed modular seat architectures for both front and rear seats. It produces components for seat assemblies, such as seat frames, recliner mechanisms, seat tracks, seat trim covers, headrests and seat foam.

The Company competes with Johnson Controls, Inc., Faurecia S.A., Toyota Boshoku Corporation, TS Tech Co., Ltd. and Magna International Inc.

EPMS Segment

The EPMS segment consists of the design, manufacture, assembly and supply of electrical distribution systems and components for traditional powertrain vehicles, as well as for hybrid and electric vehicles. Electrical distribution systems are comprised primarily of wire harness assemblies, terminals and connectors and control modules, including juncti! on boxes and fuse boxes. Wire harness assemblies consist of a collection of wiring and terminals and connectors that connect all of the various electrical and electronic devices within the vehicle to each other and/or to a power source.

Electrical distribution systems are networks of wiring and associated control devices that route electrical signals and manage electrical power within a vehicle. Wire harness assemblies consist of raw, coiled wire, which is cut to length and terminated. Individual circuits are assembled together on a jig or table, inserted into connectors and wrapped or taped to form wire harness assemblies.

Wireless products send and receive signals using radio frequency technology. The Companys wireless systems include passive entry systems and dual range/dual function remote keyless entry systems. Passive entry systems allow the vehicle operator to unlock the door without using a physically activating a remote keyless fob. Dual range/dual function remote keyless entry systems allow a single transmitter to perform multiple functions. The lighting control module integrates electronic control logic and diagnostics with the headlamp switch. Entertainment products include radio amplifiers, sound systems, in-vehicle television tuner modules and floor-, seat- or center console-mounted Media Console with a flip-up screen that provides digital video disc (DVD) and video game viewing for back-seat passengers.

The Company competes with Yazaki Corporation, Sumitomo Corporation, Delphi Automotive PLC, Leoni AG and Furukawa Electric Co., Ltd., TE Connectivity, Ltd., Continental AG, Hella, Inc., Robert Bosch LLC, Magna E-Car Systems GmbH & Co OG and Hitachi, Ltd.

Advisors' Opinion:

• [By Rich Smith]

  Shares of auto-parts makers such as Lear (NYSE: LEA  ) and Magna International (NYSE: MGA  ) have rocketed this past year, outperforming the S&P 500 with 46% and 56% returns, respectively. Yet Johnson Cont! rols stoc! k has lagged the market average by more than five points. Why?

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-up-and-coming-stocks-to-invest-in-2015.html

Top 10 Medical Companies To Own In Right Now

With shares of Clorox (NYSE:CLX) trading around $82, is CLX an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Clorox�is a manufacturer and marketer of consumer and professional products. Clorox operates in four segments: Cleaning, Household, Lifestyle and International. Clorox sells its products primarily through merchandisers, grocery stores, other retail outlets, distributors and medical supply providers. The company’s products include its namesake bleach and cleaning products, Clorox Healthcare, HealthLink, Aplicare and Dispatch products, Green Works naturally derived home care products, Pine-Sol cleaners, Poett home care products, Fresh Step cat litter, Glad bags, wraps and containers, Kingsford charcoal, Hidden Valley and K C Masterpiece dressings and sauces, Brita water-filtration products, and Burt’s Bees products. Many of the general products provided by Clorox are considered necessities by many consumers and companies worldwide. Look for Clorox to provide products that will continue to be enjoyed and needed.

Top Casino Stocks To Invest In 2015: Protalix Biotherapeutics Inc (PLX)

Protalix BioTherapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system, ProCellEx. Using its ProCellEx system, the Company is developing a pipeline of biosimilar or generic versions of recombinant therapeutic proteins based on its plant cell-based expression technology, which focuses pharmaceutical markets and that rely upon known biological mechanisms of action. ProCellEx protein expression system consists of a set of technologies and capabilities for the development of recombinant proteins, including advanced genetic engineering technology and plant cell-based protein expression methods. Its ProCellEx protein expression system is built on flexible custom-designed bioreactors made of polyethylene and optimized for the development of complex proteins in plant cell cultures. In June 2010, it had completed the preliminary phase I clinical trial of PRX-105.

Taliglucerase Alfa

Taliglucerase alfa is a plant cell expressed recombinant glucocerebrosidase enzyme (GCD) for the treatment of Gaucher disease. The Company has commenced pre-clinical studies of an oral form of taliglucerase alfa. Its oral taliglucerase alfa is a plant cell expressed form of GCD that is naturally encapsulated within carrot cells genetically engineered to express the GCD enzyme. Pre-clinical studies of oral taliglucerase alfa demonstrate the stability of the enzyme in the cell and the capacity of the cell�� cellulose wall to protect the enzyme against degradation in the digestive tract in an in-vitro model of the stomach and intestines. Additionally, rats fed with lyophilized carrot cells expressing GCD have accumulated the active enzyme in the target organs; the spleen and liver. As of December 31, 2010, the Company had completed Phase III Clinical Trial.

PRX-102

The Company is developing PRX-102, its plant cell expressed modified version of the recombinant ! alpha-GAL-A protein, a therapeutic enzyme for the treatment of Fabry disease. Fabry disease is a rare, hereditary, genetic lysosomal storage disorder in humans caused by an X-lined deficiency of the alpha-GAL-A enzyme. The Company is in the animal evaluation testing phase of the development of PRX-102, which tests are based on a mouse model for Fabry disease.

Acetylcholinesterase

Protalix Ltd. is a wholly owned subsidiary of the Company is licensed the rights to certain technology under a research and license agreement with Yissum Research and Development Company (Yissum) and the Boyce Thompson Institute, Inc. Pursuant to the agreement, the Company is developing PRX-105, a plant cell-based acetylcholinesterase (AChE) and its molecular variants for the use in several therapeutic and prophylactic indications, as well as in a biodefense program and an organophosphate-based pesticide treatment program.

As of December 31, 2010, its in-vitro experiments of PRX-105 have shown that the acetylcholinesterase enzyme in its ProCellEx protein expression system demonstrates biological activity on biochemical and cellular levels. In addition, early animal studies demonstrated that the acetylcholinesterase expressed in its ProCellEx protein expression system was able to treat animals exposed to the nerve gas agent analogues, both when injected with its acetylcholinesterase product candidate immediately before exposure or when injected after exposure. In March 2010, it initiated a preliminary phase I clinical trial of PRX-105, which the Company completed in June 2010.

pr-antiTNF

pr-antiTNF is a candidate for the treatment of certain autoimmune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing, spondylitis, psoriatic arthritis and plaque psoriasis. The Company has designed the antiTNF as pr-antiTNF. pr-antiTNF is a plant cell-expressed recombinant fusion protein made from the soluble form of the human TNF receptor (TNFR), f! used to t! he Fc component of a human antibody domain. pr-antiTNF has an identical amino acid sequence to Enbrel and its in-vitro and preclinical animal studies have demonstrated that pr-antiTNF exhibits similar activity to Enbrel. Specifically, pr-antiTNF binds TNF thereby inhibiting it from binding to cellular surface TNF receptors and protects L929 cells from TNF-induced apoptosis in a dose-dependent manner.

The Company competes with Genzyme, Actelion, Crucell N.V., Biolex, Inc., Chlorogen, Inc., Greenovation Biotech GmbH, Symbiosys, Novartis AG/Sandoz Pharmaceuticals, BioGeneriX AG, Stada Arzneimittel AG, BioPartners GmbH and Teva.

Advisors' Opinion:

• [By Maxx Chatsko]

  Industrial biotech isn't the only industry headed to Brazil. Protalix (NYSEMKT: PLX  ) entered into a technology transfer agreement with Brazil's Ministry of Health last week that will pay the company $280 million. The deal is big news for Protalix's first product, Elelyso/Uplyso, which was developed with partner Pfizer (NYSE: PFE  ) . The treatment is approved as an enzyme replacement therapy, or ERT, for adults with type 1 Gaucher disease, and it marks a huge step forward for the future of biomanufacturing. In the following video, Fool contributor Maxx Chatsko explains what this means for the product's commercialization and the adoption of Protalix's novel plant cell-based expression system for therapeutic proteins.

• [By Keith Speights]

  Other investors might wish that Pfizer would use some of its cash to acquire a few smaller companies. Protalix BioTherapeutics (NYSEMKT: PLX  ) has been mentioned as one possible candidate. The two companies already partner together on Gaucher disease drug Elelyso. In February, Protalix spurred rumors that Pfizer could be interested in buying the company after it announced that it had engaged Citigroup to pursue a "broad array of strategic alternatives."

Top 10 Medical Companies To Own In Right Now: Cambridge Heart Inc (CAMH)

Cambridge Heart, Inc., incorporated on January 16, 1990, is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. The Company's products incorporate its technology for the measurement of Microvolt T-Wave Alternans (MTWA). The MTWA Test is conducted by elevating the patient's heart rate through exercise as performed on a treadmill similar to a stress test, pharmacologic agents, or pacing with electrical pulses.

The Company's products, including its first generation HearTwave System and second generation HearTwave II System, CH 2000 Cardiac Stress Test System, MTWA original equipment manufacturer (OEM) Module (MTWA Module) and Micro-V Alternans Sensors have received 510(k) clearance from the United States Food and Drug Administration (FDA) for sale in the United States. The Company's products have also received the Conformite Europeenne (CE) mark for sale in Europe. The Company's first generation HearTwave System, CH 2000 Cardiac Stress Test System and the HearTwave II System have been approved for sale by the Japanese Ministry of Health Labor and Welfare.

The Company's 510(k) clearance allows the Company's MTWA Test to be used to test patients with known, suspected, or at risk of ventricular tachyarrhythmia and/or sudden cardiac arrest, and allows the claim that its MTWA Test is predictive of those events. The MTWA Module is designed to work with existing cardiac stress test platforms distributed by other manufacturers as an add-on module to enable MTWA testing to be performed using the Company's Micro-V Alternans Sensors.

The Company's HearTwave II System, which has replaced the Company's original HearTwave System, is used to perform both MTWA testing and standard cardiac stress testing. In addition to MTWA measurement, the Company's HearTwave II System is a cardiac diagnostic system designed to support a range of customized protocols for the conduct of cardiac exercise stress testing. The Comp! any's Micro-V Alternans Sensors are single patient use, multi-segment electrodes. The Company's CH2000 is a cardiac diagnostic system designed to support a range of customized protocols for the conduct and measurement of cardiac exercise stress testing.

The Company competes with GE Medical Systems.

Advisors' Opinion:

• [By Peter Graham]

  Last Friday, small cap stocks Cambridge Heart, Inc (OTCMKTS: CAMH), Abby Inc (OTCMKTS: ABBY) and Grillit Inc (OTCMKTS: GRLT) surged 176.92%, 71.2% and 24.07%, respectively. Of course, that was last week and today is a new trading week. So what should investors and traders alike be prepared for this week with these three small caps? Here is a closer look to help you decide on an investing or trading strategy:

  Cambridge Heart, Inc (OTCMKTS: CAMH) Recently Changed Its Board

  Small cap Cambridge Heart, Inc is a healthcare company engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. On Friday, Cambridge Heart, Inc surged 176.92% to $0.018 for a market cap of $1.80 million plus CAMH is up 20% since the start of the year and down 86.1% over the past five years according to Google Finance.

Top 10 Medical Companies To Own In Right Now: Evolva Holding SA (EVE)

Evolva Holding SA (Evolva) discovers and provides ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create small molecule compounds and their production routes. The Company�� nutrition and consumer products include Pomecins, saffron, stevia, vanilla and resveratrol. The Company�� pharmaceuticals products include EV-077 and EV-035. In pharmaceuticals, the Company focuses on oral, small molecule drugs with application in complications of diabetes and infectious diseases. Pomecins are Evolva�� compounds. Evolva is focused on two members of the family - Pomecin A and Pomecin B. EV-035 is a bacterial type II topoisomerase inhibitor. Evolva is developing EV-077 for the treatment of diabetic complications. It is an oral, small molecule compound, belonging to a structural class. Advisors' Opinion:

• [By Glenwoods]

  Earlier this year the giant food processor, Cargill, partnered with the small Swiss company, Evolva (SIX:EVE), which was developing its own stevia-based fermentation process, also in the pilot stage. As noted earlier in the article, Cargill is in a partnership with Coca-Cola for Truvia, the bestselling stevia product on the market. The success of the Cargill/Evolva partnership could have big implications not just for Cargill and Coca-Cola, but also on the entire stevia and sweetener market. I further believe the success of the partnership could have a major impact on Stevia First. If Cargill�� fermentation method produces a better tasting stevia product at a lower cost it would give Coca-Cola a considerable advantage over the other beverage bottlers, food manufacturers, and stevia producers. Such an outcome would force these companies to scramble to find a similar method in order to compete. There would be a very good chance that rival companies, in order to stay in the game, would have to turn to the other company developing a fermentation-based stevia product-- Stevia First. If that happens Stevia First�� value would rise considerably.

Top 10 Medical Companies To Own In Right Now: Integra LifeSciences Holdings Corp (IART)

Integra LifeSciences Holdings Corporation (Integra), incorporated on June 19, 1989, is an integrated medical technology company. Integra offers solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. The Company has developed numerous product lines for applications ranging from burn and deep tissue wounds to regeneration of dura mater in the brain and repair of nerve and tendon. It operates in five business segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. The International segment sells similar products to Europe, Middle East and Africa, and Central/South America, Asia-Pacific and Canada. On April 29, 2013, the Company launched the Integra Compact Cranial Closure System, which provides titanium implants for non-loadbearing (non-facial) operative cranial neurosurgical procedures. On April 30, 2013, it released its Hollywood VI intervertebral body fusion device (IBD) system. In January 2014, Integra LifeSciences Holdings Corp completed the acquisition of DuraSeal product lines from Covidien. In January 2014, Covidien PLC completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation.

U.S. Neurosurgery

The Company�� U.S. Neurosurgery sales organization sells a full line of products for neurosurgery and neuro critical care. It has products for each step of a cranial procedure and the care of the patient after surgery. Its key products include dural repair products, cerebral spinal fluid (CSF) management devices, tissue ablation equipment, intracranial monitoring equipment and cranial stabilization equipment. The Company sells equipment used in the neurosurgery operating room and neurosurgery intensive care unit (NICU).

U.S. Extremities

Extremity reconstruction includes the repair of soft tissue and the orthopedic reconstruction of bone in the foot, ankle and leg below the knee (Lower Extremity), and the hand, ! wrist, elbow and shoulder (Upper Extremity). Its key products include bone and joint fixation devices, implants and instruments for osteoarthritis, rheumatoid arthritis, wrist arthroplasty, carpel tunnel syndrome, and cubital tunnel syndrome. Other key products include its regenerative medicine devices for the treatment of acute and chronic wounds, peripheral nerve repair and protection and tendon repair, and bone graft substitutes.

U.S. Instruments

Integra�� U.S. Instruments business is a surgical instrument suppliers in the United States. Its portfolio includes over 60,000 instrument patterns and surgical products sold a range of users, including hospitals, surgery centers, and physician, dental and veterinary offices. In addition to selling hand-held instruments, it sells surgical headlight systems and table-mounted retractors. The Company�� brands include Jarit, Miltex, Padgett, Ruggles, Luxtec and Omni-Tract.

U.S. Spine and Other

Integra�� U.S. Spine and Other segment offer spinal fusion technologies that surgeons use along the full length of the spine, as well as a range of related orthobiologics. During the year ended December 31, 2012, its Spine business launched multiple new implants into the integrated interbody fusion device market and the deformity market. Its key spinal hardware products include integrated interbody fusion devices, minimally invasive solutions, and deformity correction. It markets and sells a complete line of orthobiologics, including demineralized bone products, collagen ceramic matrices and pure synthetic bone grafting solutions, to neurosurgeons, and spine, orthopedic, trauma, and foot and ankle surgeons. Integra sells its products through specialty distributors focused on its spine and orthopedic surgeon customers, as well as through some direct sales representatives. This segment also includes private-label sales of a set of its regenerative medicine technologies. Its customers are other large medical technology! companie! s that sell to end markets primarily in orthopedics and wound care.

The Company competes with Johnson & Johnson, Synthes, Inc., Stryker Corporation, Tornier, Inc., Wright Medical Group, Inc., Zimmer, Inc., Small Bone Innovations, Inc., Medtronic, Inc., Globus Medical Inc., NuVasive, Inc., Orthofix, Alphatec Spine, Inc., B. Braun Medical Inc., CareFusion and Symmetry Medical.

Advisors' Opinion:

• [By Seth Jayson]

  Basic guidelines
  In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Integra LifeSciences Holdings (Nasdaq: IART  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Integra LifeSciences Holdings doing by this quick checkup? At first glance, OK, it seems. Trailing-12-month revenue increased 4.5%, and inventory increased 4.1%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue expanded 0.2%, and inventory increased 4.1%. Over the sequential quarterly period, the trend looks worrisome. Revenue dropped 8.3%, and inventory grew 4.5%.

• [By Sean Williams]

  What: Shares of Integra LifeSciences (NASDAQ: IART  ) , a manufacturer of surgical instruments and medical implants, fell as much as 13% after the company announced a voluntary recall of certain products at its Anyasco manufacturing facility in Puerto Rico.

• [By Keith Speights]

  Recall recoil
  Medical instrument maker Integra LifeSciences (NASDAQ: IART  ) shares dropped 11% this week. The stock's fall stemmed from a product recall announced on Wednesday.�

• [By John Udovich]

  On Thursday, small cap medical device stock Integra Lifesciences Holdings Corp (NASDAQ: IART) jumped 9.90% after the FDA completed its inspection of the company's manufacturing facility which led to positive comments from analysts, meaning it might be time to take a look at its performance verses that of medical device ETFs like iShares Dow Jones US Medical Device ETF (NYSEARCA: IHI) and SPDR S&P Health Care Equipment ETF (NYSEARCA: XHE).

Top 10 Medical Companies To Own In Right Now: Prosensa Holding NV (RNA)

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company�� primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington�� disease. The Company�� clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company�� platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

DMD is a rare, severe muscle wasting disease that occurs in up to 1 in 3,500 male births. It is commonly diagnosed between the ages of three to five, when boys begin to show signs of impaired motor development. PRO044, the Company�� product candidate, addresses a separate sub-population of DMD patients. The Company developed PRO044 using its exon-skipping technology to generate a product candidate with the same mechanism of action that is used by drisapersen.

Advisors' Opinion:

• [By Keith Speights]

  An "alley-oop" from the opponent
  Prosensa (NASDAQ: RNA  ) shares made something of a slam dunk this week, jumping more than 16%. That dunk was made with what amounts to an "alley-oop" from its primary rival, Sarepta Therapeutics (NASDAQ: SRPT  ) .

Top 10 Medical Companies To Own In Right Now: Curis Inc.(CRIS)

Curis, Inc., a drug discovery and development company, focuses on the research and development of cancer therapeutics. The company, under collaboration with Genentech, Inc., is conducting a pivotal Phase II clinical trial on its lead molecule, GDC-0449 in advanced basal cell carcinoma patients, as well as various Phase II clinical trials in first-line metastatic colorectal cancer and advanced ovarian cancer patients. It is also evaluating CUDC-101, a small molecule that is in a Phase I clinical testing and is designed to target histone deacetylase, epidermal growth factor receptor, and epidermal growth factor receptor 2. In addition, Curis has a development candidate, Debio 0932, which is a Heat Shock Protein 90 or Hsp90 inhibitor. The company holds a license agreement with Debiopharm related to its Hsp90 technologies. Further, it involves in preclinical testing for the development of candidates from its targeted cancer programs. The company was founded in 2000 and is base d in Lexington, Massachusetts.

Advisors' Opinion:

• [By Monica Gerson]

  Curis (NASDAQ: CRIS) dipped 18.97% to $3.16 in the pre-market session after the company reported Q3 financial results and provided CUDC-427 development update.

Top 10 Medical Companies To Own In Right Now: Sucampo Pharmaceuticals Inc (SCMP)

Sucampo Pharmaceuticals, Inc., incorporated on December 9, 2008, is a global biopharmaceutical company focused on research, discovery, development and commercialization of drugs based on ion channel activators known as prostones. The Company�� prostone-based compounds target the ClC-2 and big potassium (BK), ion channels. It is focused on developing prostones to treat gastrointestinal, ophthalmic, neurologic, and oncology-based inflammatory disorders, and is also considering other therapeutic applications of its drug technology. The Company�� products include AMITIZA (lubiprostone) and RESCULA (unoprostone isopropyl).

AMITIZA

The Company�� AMITIZA is being marketed in the United States for three gastrointestinal indications under a license agreement, or the Takeda Agreement, with Takeda Pharmaceutical Company Limited, or Takeda. The three gastrointestinal indications include chronic idiopathic constipation (CIC), in adults, irritable bowel syndrome with constipation (IBS-C), in adult women, and opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. AMITIZA for OIC received approval from the United States Food and Drug Administration (FDA), in April 2013. In Japan, AMITIZA is marketed under a license, commercialization and supply agreement, or the Abbott Agreement, with Abbott Japan Co. Ltd. (Abbott), for the gastrointestinal indication of chronic constipation (CC), excluding constipation caused by organic diseases. In Switzerland, the Company is marketing AMITIZA.

RESCULA

The Company holds license agreements for RESCULA in the United States and Canada and the rest of the world, with the exception of Japan, Korea, Taiwan and the People�� Republic of China. The Company is commercializing RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% for the lowering of intraocular pressure (IOP), in patients with open-angle glaucoma or ocular hypertension in the United States. RESCULA may be used as an agent or concomit! antly with other topical ophthalmic drug products to lower intraocular pressure. RESCULA is a BK channel activator and has a different mechanism of action than other IOP lowering agents on the market.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 stock that's starting to trend within range of triggering a major breakout trade is Sucampo Pharmaceuticals (SCMP), which is engaged in the discovery, development and commercialization of proprietary drugs based on prostones, and other novel drug technologies. This stock is off to a decent start in 2013, with shares up by 26%.

  If you take a look at the chart for Sucampo Pharmaceuticals, you'll notice that this stock has been downtrending badly for the last four months, with shares dumping hard from its high of $10.48 to its recent low of $5.40 a share. During that downtrend, shares of SCMP have been consistently making lower highs and lower lows, which is bearish technical price action. That said, the downside volatility for SCMP looks to be over in the short-term since the stock has started to reverse its downtrend and enter an uptrend. That reverse is quickly pushing shares of SCMP within range of triggering a major breakout trade above a key downtrend line.

  Traders should now look for long-biased trades in SCMP if it manages to break out above some near-term overhead resistance levels at $6.33 to $6.66 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 115,383 shares. If that breakout triggers soon, then SCMP will set up to re-test or possibly take out its next major overhead resistance levels at $7.09 to $7.67 a share. Any high-volume move above those levels will then give SCMP a chance to tag $8 to $9 a share.

  Traders can look to buy SCMP off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $5.58 to $5.40 a share. One can also buy SCMP off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By James Brumley]

  Still, for the nimble who know when to get out, OREX is one of the few cheap stocks worth a closer look.

  Sucampo Pharmaceuticals (SCMP)

  Finally, though the price of $7.60 clearly qualifies it as one pf the cheapest of the cheap stocks out there in the pharmaceutical world, that’s not the reason Sucampo Pharmaceuticals (SCMP) may be worth a look here. It’s the 30% slide we’ve seen SCMP stock suffer since peaking in mid-January. It’s not a pullback that’s bound to go unchallenged by the bulls.

Top 5 Paper Stocks To Watch Right Now

Top 5 Paper Stocks To Watch Right Now: TriSta r Wellness Solutions Inc (TWSI)

TriStar Wellness Solutions, Inc., formerly Biopack Environmental Solutions Inc., incorporated on August 28, 2000, is engaged in developing, marketing and selling, NCP's Beaute de Maman product lines, which is a line of skincare and other products specifically targeted for pregnant women, as well developing the Soft and Smooth Assets. The Company supplied biodegradable food containers and industrial packaging products to multinational corporations, supermarket chains and restaurants located across North America, Europe and Asia. In May 2013, the Company acquired HemCon Medical Technologies Inc.

The Companys priority direct-to-consumer target markets are focused on womens health and wound care. The second core product area is directed at the Direct-to-Consumer (DTC) wound care market space. During the year ended December 31, 2012, the Company focused the sales and marketing resources for the Beaute de Maman brand on efficient Internet portals via the bran d Website and selected Web-based retailers.

Advisors' Opinion:

• [By Peter Graham]

  Last Friday, small cap stocks Tristar Wellness Solutions Inc (OTCMKTS: TWSI) jumped 14.94% while Hybrid Coating Technologies (OTCBB: HCTI) and Bulova Technologies Group, Inc (OTCMKTS: BTGI) sank 23.53% and 13.04%, respectively. It should be mentioned that only one of these small cap stocks appears to be the subject of paid promotions or investor relations type activities. So what will these three small cap stocks do for investors this week? Here is a quick reality check to help you decide on a trading or investing strategy:

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-5-paper-stocks-to-watch-right-now-2.html

Top Cheapest Stocks To Watch For 2014

He chooses Kotak Preferred Term Plan as the best offline and the cheapest plan.

Below is the edited transcript of his interview to CNBC-TV18.

Q: Should I invest in LIC Policy or Mutual Funds?

A: This is a very frequently asked question.

You should keep objectives of investment and insurance segregated. If you try to meet both the objectives with the same investment, you would be compromising on either of those. Buy yourself a Term Plan, which would give you the insurance cover. Also buy a mutual fund, which would give you investment benefits.

There could be individuals who are not very disciplined on the savings front. They should choose a more mandated policy, wherein insurance policy mandates you not to skip a couple of installments just like the mutual fund would have.

Break your expense of a month into two portions. Then see whether you over an expense bit. If you have 25 percent and more into expenses which could have been avoided, then it clearly signifies that you are not disciplined. So you should choose a more stringent policy.

Top 5 Value Stocks To Invest In Right Now: Arcadis NV (ARCAD)

Arcadis NV is a Netherlands-based international engineering and consultancy firm, providing consultancy, design, engineering and management services in infrastructure, water, environment and buildings. The Company develops, designs, implements, maintains and operates projects for companies and governments. The Company divides its business into four business lines: Infrastructure, which encompasses services for transportations, land development, energy and mining; Water, focused on water planning, wastewater and water management and consulting services; Environment, focused on activities that protect the environment and enhance sustainability, and Buildings, related to homebuilding as well as commercial and industrial buildings and facilities construction. Additionally, it works in partnership with UN-HABITAT, the United Nations agency for human settlements. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Companies like Expedia Inc. (EXPE), which provides online travel booking services, and Arcadis NV (ARCAD), a Dutch designer of bridges and dikes, are likely to increase profit at a faster pace than larger firms during an improving economy, Duret said. Smaller companies are also less leveraged, with U.S. mid-caps holding 46 percent less debt per share than firms listed on the S&P 500, data compiled by Bloomberg show.

Top Cheapest Stocks To Watch For 2014: Buckeye Partners L.P. (BPL)

Buckeye Partners, L.P. owns and operates refined petroleum products pipeline systems in the United States. Its Pipelines & Terminals segment transports refined petroleum products; and provides bulk storage and terminal throughput services in the continental United States. This segment owns and operates approximately 6,000 miles of pipeline serving approximately 110 delivery locations; and has 100 active products terminals with aggregate storage capacity of approximately 40 million barrels. The company’s International Operations segment provides marine terminal throughput, marine bulk storage, and other related services. This segment operates through two petroleum product terminals located on Grand Bahama Island, in The Bahamas and in Puerto Rico with an aggregate storage capacity of approximately 30 million barrels. Its Natural Gas Storage segment provides natural gas storage services through a facility with approximately 30 billion cubic feet of working natural gas storage capacity located in Northern California. The company’s Energy Services segment engages in the wholesale distribution of refined petroleum products, including gasoline; propane; ethanol; biodiesel; and petroleum distillates, such as heating oil, diesel fuel, and kerosene to wholesalers and commercial users. Its Development and Logistics segment provides contract operations, construction management, and asset development services to third-party pipeline and energy assets, and energy companies in the United States. This segment owns and operates 2 underground propane storage caverns with approximately 800,000 barrels of throughput and storage capability in Indiana and Illinois; and a 30-mile ammonia pipeline and 25 miles of pipeline in Texas. Buckeye GP LLC serves as the general partner of the company. Buckeye Partners, L.P. was founded in 1886 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Matt DiLallo]

  Logistics hub
  Another top stock to consider buying is midstream operator Buckeye Partners (NYSE: BPL  ) . While a bulk of the company's assets are in the U.S., the crown jewel is its BORCO storage terminal business in the Bahamas. This asset is of strategic importance to the region as it provides Latin American producers with storage and blending options. As you can see in the map below, the asset's strategic location puts it in the best position to be a regional hub for the movement of crude oil and refined products. If oil production in the region comes as expected, the company has more than enough room to double its current capacity, which means lots of growth potential for investors.�

• [By Matt DiLallo]

  Buckeye Partners (NYSE: BPL  ) is one of the more unique master limited partnerships in the business. Its pipeline and terminal business is solely focused on transporting and storing petroleum products. Even more unique to Buckeye is its international pipeline and terminal business which provided 23.6% of the company's adjusted EBITDA last year. That segment, which we'll take a closer look at, should grow to become a much larger portion of its income given the exceptional opportunities it has to grow.�

Top Cheapest Stocks To Watch For 2014: ForeverGreen Worldwide Corp (FVRG)

ForeverGreen Worldwide Corporation, incorporated on March 18, 1999, is a holding company that operates through its wholly owned subsidiary, ForeverGreen International, LLC. The Company's product philosophy is to develop, manufacture and market the science and nature through formulations as the Company produces and manufacture a wide arrays of whole foods, nutritional supplements, personal care products and essential oils. The Company provides health answers, not only through exclusive nutritional whole food beverages, but also by providing a broad product lines of delicious whole foods that can be eaten for every meal, instead of the processed, fatty and preservative-laden synthetic meals prevalent in society.

The Company provides the every-meal answer with a variety of appetizing healthy food products that allow its Members and customers to eat healthy for every meal and snack throughout the day. In addition, the Company provides healthy personal care products as an alternative to the chemical-laden and synthetic products in the marketplace that may potentially negatively impacts its health. The Company's products, along with a distinct and fresh corporate philosophy and message of physical, mental, emotional and spiritual health through service to community and others, attract consumers as well as Members who wish to own a home-based business selling the Company's products and spreading its health message.

The Company's primary product is FrequenSea, a whole-food beverage consisting of a blend of marine phytoplankton, ionic sea minerals, frankincense, rose, ginger and aloe vera in a base of blueberry, cranberry and lime juice concentrate. soluble. FrequenSea is sold as a single bottle, in individual single-serving packets or even in four-bottle packs. The marine phytoplankton in FrequenSea contains more than 200 different sea algae that are all processed through patent-pending harvesting processes. Azul is a rich-in-antioxidant, delicious powdered blend of 24 raw whole foo! d and fruit ingredients and probiotics that are naturally dried and blended to preserve their natural integrity.The Company's whole food offerings consist of a variety of healthy, natural food products that are made onsite in the Company's whole-food manufacturing facility. Versativa Pulse based with hemp seed, consists of 17 different nuts, seeds, fruits, grains and other whole foods. Pulse is offered in various flavors, either loose in bags or in snack bars, and may be used as a snack or a meal replacement.

The Company competes with NuSkin, Neways, Young Living Essential Oils, Amway Corporation, Herbalife and NuSkin Enterprises.

Advisors' Opinion:

• [By CRWE]

  Last Friday, FVRG had shed (-15.38%) down -0.100 at $.550 with 20,050 shares in play at the close (ref. google finance August 16, 2013 ��Close).

  ForeverGreen Worldwide Corporation previously reported that sales are continuing to flourish. Sales for July 2013 increased to in excess of $1.44 million compared to $1.04 million during July 2012, an increase of 38.1%. Sequentially, sales increased 12.3% compared to June 2013.

Top Cheapest Stocks To Watch For 2014: Petroquest Energy Inc(PQ)

PetroQuest Energy, Inc. operates as an independent oil and gas company. It engages in the acquisition, exploration, development, and operation of oil and gas properties in Oklahoma, Arkansas, and Texas, as well as onshore and in the shallow waters offshore the Gulf Coast Basin. As of December 31, 2009, the company had estimated proved reserves of 1,931 thousand barrels of oil and 167,361 million cubic feet equivalent of natural gas. It owned working interests in 9 net producing oil wells and 277 net producing gas wells. PetroQuest Energy was founded in 1983 and is headquartered in Lafayette, Louisiana.

Advisors' Opinion:

• [By Jon C. Ogg]

  PetroQuest Energy Inc. (NYSE: PQ) was downgraded to Neutral from Overweight at J.P. Morgan.

  Rubicon Technology Inc. (NASDAQ: RBCN) was downgraded to Underperform from Perform at Oppenheimer.

• [By Nitish]

  PetroQuest Energy, Inc. (PQ) last month announced results for the second quarter of 2014. The following compares certain second quarter 2014 metrics to those of the second quarter of 2013, highlighting the company's continued growth driven by its successful drilling programs in Oklahoma and Texas, its acquisition of certain Gulf of Mexico assets in July 2013 ("Gulf of Mexico Acquisition") and stronger natural gas prices:

Top Cheapest Stocks To Watch For 2014: Investment Technology Group Inc (ITG)

Investment Technology Group, Inc. (ITG), incorporated on March 10, 1994, is an independent execution and research broker that partners with global portfolio managers and traders to provide data-driven insights throughout the investment process. It operates in three segments: United States Operations, Canadian Operations, European Operations and Asia Pacific Operations. The United States Operations segment provides electronic and trade execution, trade order and execution management, network connectivity, analytical products and investment research services. The Canadian and Asia Pacific Operations segments provide electronic and high-touch trade execution, trade execution management, network connectivity, analytical products and investment research services. The European Operations segment provides electronic and high-touch trade execution, trade order and execution management, network connectivity and analytical products and includes a technology research and development facility in Israel.

ITG offers a range of solutions for asset managers in the areas of electronic brokerage, research sales and trading, trading platforms and analytics. These offerings include trade execution services and solutions for portfolio management, as well as investment research, pre-trade analytics and post-trade analytics and processing. Its principal subsidiaries include: ITG Inc., AlterNet Securities, Inc., ITG Derivatives LLC, Investment Technology Group Limited, ITG Australia Limited, ITG Canada Corp., ITG Hong Kong Limited, ITG Software Solutions, Inc. and ITG Solutions Network, Inc.

Electronic Brokerage

ITG electronic brokerage services include self-directed trading using algorithms, smart routing and matching through POSIT in cash equities (including single stocks and portfolio lists), futures and options. ITG Algorithms and ITG Smart Router offer portfolio managers and traders a way to trade orders quickly, from any ITG Execution Management System (EMS) or ITG Order Managemen! t System (OMS) and third-party trading platforms. ITG Algorithms help users pursue execution through two suites: ITG Single Stock Algorithms and ITG List-Based Algorithms. ITG Smart Router offers an alternative to routing trades that can help capture liquidity with a combination of speed and confidentiality. These routers continuously scan markets for liquidity with an emphasis on trading without displaying the order.

POSIT Alert is a buyside-only block crossing mechanism within POSIT. POSIT Alert scans uncommitted shares from participating clients. When a crossing opportunity is detected, POSIT Alert notifies the relevant users that a matching opportunity exists. POSIT Marketplace provides access to POSIT liquidity, the dark pools of other ATSs, and certain exchange hidden order types. POSIT Marketplace is a dark pool aggregator that provides clients with access to a range of liquidity destinations. POSIT Marketplace uses advanced quantitative techniques in an effort to protect clients from gaming and to interact with quality liquidity. ITG Derivatives provides electronic-listed futures and options trading, including algorithmic trading and direct market access. ITG offers options features for traders employing volatility or delta-neutral strategies and also provides low-latency application programming interfaces.

ITG offers guidance, administration, and consolidation of client commission arrangements across the range of preferred brokerage and research providers of its clients using ITG Commission Manager, a robust, multi-asset Web-based commission management portal. Through stock borrow and stock loan transactions, ITG facilitates shortened or extended settlement periods to help clients meet their internal cash flow needs.

Research Sales & Trading

ITG provides unbiased, data-driven equity research through its ITG Investment Research subsidiary. This offering has expanded ITG's client relationships beyond the trading desk to chief investment officer! s, portfo! lio managers and analysts. ITG Market Research offers market research capabilities to corporate clients within the healthcare and telecom industries. The healthcare market research practice combines survey results with empirical data to deliver syndicated and custom reporting capabilities. ITG provides high-touch sales trading and portfolio trading for institutional clients. ITG's high-touch trading desk is staffed with experienced trading professionals who provide ITG clients with execution expertise and also convey trading ideas based on ITG Investment Research.

Trading Platforms

ITG EMSs are designed to meet the needs of disparate trading styles. Triton Derivatives is a broker-neutral direct access EMS that provides traders with access to scalable, low-latency, multi-asset trading opportunities. ITG OMS combines portfolio management, compliance functionality (ITG Compliance Monitoring System), trading and post-trade processing (ITG Trade Operations Outsourcing), and a fully integrated and supported financial services communications network (ITG Net) with a consolidated, outsourced service for global trade matching and settlement (ITG Trade Operations Outsourcing) that provides connectivity to the industry's post-trade utilities, support for multiple, flexible settlement communications methods and a real-time process monitor. ITG Net is a global financial communications network that provides secure, reliable and fully supported connectivity between buy-side and sell-side firms for order routing and indication-of-interest messages from ITG and third-party trading platforms.

ITG's commitment to execution platforms also extends to broker-neutral operational services to help ensure that trades clear and settle efficiently, and to significantly lower the transaction costs associated with trade tickets. The ITG Smart Trading Analytics suite enables portfolio managers and traders to improve execution performance before the trade happens (pre-trade) and during trading ! (real-tim! e) by providing reliable portfolio analytics and risk models that help them perform predictive analyses, manage risk, change strategy and reduce trading costs. ITG Transaction Cost Analysis (TCA) offers measurement and reporting capabilities to analyze performance across the trading continuum. ITG Alpha Capture Reporting measures cost at every point of the investment process and provides portfolio managers with quarterly analytical reviews, written interpretations and on-site consultative recommendations to enhance performance.

ITG provides tools to assist asset managers with portfolio decision-making tasks from portfolio construction and optimization to the enterprise challenges of global, real-time portfolio compliance monitoring and the fair valuation of securities. ITG Portfolio Fair Value Service helps mutual fund managers meet their obligations to investors and regulators to fairly price the securities within their funds, and helps minimize the impact of market timing. ITG Portfolio Optimization System allows portfolio managers to develop new portfolio construction strategies and solve complex optimization problems. ITG Portfolio Optimization System allows users to accurately model tax liability, transaction costs and long/short objectives, while adhering to diverse portfolio-specific constraints.

Non-U.S. Operations

ITG has a development center in Tel Aviv. In Asia Pacific, ITG has offices in Sydney, Melbourne, Hong Kong and Singapore. Local representation in regional markets provides an important advantage for ITG. ITG also provides electronic and high-touch trading for Latin American equities, including algorithms for Brazil and Mexico, from its New York headquarters.

Canadian Operations

ITG Canada provides electronic brokerage services, including ITG Algorithms, ITG Smart Router and the POSIT suite, as well as high-touch agency execution and portfolio trading services. In addition, ITG Canada provides Triton, Triton Derivatives! , connect! ivity services, ITG Single Ticket Clearing, ITG Portfolio Optimization System, ITG Smart Trading Analytics, ITG TCA and investment research services. ITG Canada also engages in principal trading activities. ITG Canada's customers primarily consist of asset and investment managers, broker-dealers and hedge funds.

European Operations

ITG Europe focuses on trading European, Middle Eastern and African equities, as well as providing ITG's technologies to its clients. ITG Europe provides electronic brokerage services, including ITG Algorithms, ITG Smart Router, and the POSIT suite, as well as high-touch agency execution and portfolio trading services. ITG Europe also provides ITG OMS, Triton, connectivity services, ITG Single Ticket Clearing, ITG TCA, ITG Alpha Capture Reporting and ITG Smart Trading Analytics.

Asia Pacific Operations

ITG provides institutional investors with a range of ITG's products and services including trade execution, trade execution management through Triton, connectivity services and pre-and post-trade analysis through ITG TCA and ITG Smart Trading Analytics. Execution services are provided through electronic brokerage products such as ITG Algorithms and the POSIT suite and through an experienced high-touch agency trading services team. Other trading tools provided by ITG Hong Kong include Triton, connectivity services, ITG TCA and ITG Smart Trading Analytics. ITG Singapore provides institutional investors in Singapore with a range of ITG's products and services including electronic and high-touch execution services, trade execution management through Triton and trading analysis through ITG TCA and ITG Smart Trading Analytics.

Advisors' Opinion:

• [By victorselva]

  The Charles Schwab Corporation (SCHW) is a savings and loan holding company. The company is engaged, through its subsidiaries, in securities brokerage, banking, money management, and financial advisory services. Its subsidiaries include Charles Schwab & Co. (a leading discount broker-dealer), Charles Schwab Investment Management (a mutual fund investment advisor) and Charles Schwab Bank.In this article, let's take a look at this brokerage firm and try to explain to investors the reasons this is an apparently appealing investment opportunity.The FocusThe company provides financial services to individuals and institutional clients through two segments: Investor Services and Institutional Services. The Investor Services segment provides retail brokerage and banking services to individual investors. The Institutional Services segment provides custodial, trading, and support services to independent investment advisors. The Institutional Services segment also provides retirement plan services, specialty brokerage services, and mutual fund clearing services. The company seeks to meet the financial services needs of investors, advisers and employers. It focuses on building client loyalty with the goal of attracting new clients and serving them. Additionally, Schwab麓s strengths through shared core processes and technology advances which help create services that are scalable and consistent with the business.Interest Rates, Capital Structure and Debt-to-Capital RatioThe results are dependent on short-term interest rates, as 37% of its top line came from net interest income in the first quarter of 2014.The broker has been making significant efforts to become less dependent on interest rates, which we expect Federal Reserve will raise them in late 2014 or 2015. Also, the company麓s plan is to reach a low-cost capital structure and targets a long-term debt-to-total financial capital ratio of less than 30%.Lucrative Derivatives Trading In 2011, the company acquired Compl

• [By Jon C. Ogg]

  Investment Technology Group Inc. (NYSE: ITG) was downgraded to Market Perform from outperform by Keefe�Bruyette & Woods.

  Liquidity Services Inc. (NASDAQ: LQDT) was raised to Buy from Underperform, and the price target was raised up to $45 from $28.50, at Merrill Lynch.

Top Cheapest Stocks To Watch For 2014: Barclays PLC (JO)

Barclays PLC (Barclays) is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. The Company�� operations include its overseas offices, subsidiaries and associates. The Company operates in eight segments: UK Retail and Business Banking (UK RBB), Europe Retail and Business Banking (Europe RBB), Africa Retail and Business Banking (Africa RBB), Barclaycard, Barclays Investment Bank, Barclays Corporate Banking, Wealth and Investment Management, and Head Office and Other Operations. Advisors' Opinion:

• [By David Fabian]

  Caffeine lovers should note that coffee futures ramped sharply this week, with the iPath Bloomberg Coffee Subindex Total Return SM Index (NYSE: JO) gaining more than 14.7 percent. JO tracks liquid coffee futures contracts as traded on the NYMEX exchange.

Top Cheapest Stocks To Watch For 2014: Fresenius Medical Care Corporation (FMS)

Fresenius Medical Care AG & Co. KGaA, a dialysis company, provides products and services for patients with chronic kidney diseases. As of May 12, 2011, it provided dialysis care services to 216,942 patients through its network of 2,769 dialysis clinics primarily in North America, Europe, Latin America, the Asia-Pacific, and Africa. The company also develops and manufactures various dialysis products, including hemodialysis machines, dialyzers, hemofilters, dialysis fluid filters, tubing systems, fistula needles, dialysis related equipment, acute hemodialysis machines, plasma filters, acute tubing systems and cassettes, catheters, and related disposable products for chronic hemodialysis, acute therapy, home therapy, and therapeutic apheresis, as well as dialysis drugs. In addition, it provides laboratory services. Fresenius Medical sells its products through distributors. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

Advisors' Opinion:

• [By Ben Eisen]

  DaVita (DVA) �gained 8.9% and Fresenius (FMS) �rose 7.2%.

• [By Louie Grint]

  Still unaffected
  First, Fresenius Medical Care (NYSE: FMS  ) is the No. 1 global provider of dialysis equipment. It enjoys leading market share of almost 33% in its home country.